Authors
Loading...
In vitro analysis revealed selective cytotoxic activity of azolopyrimidines against glioblastoma and bladder carcinoma, suggesting target pathways.
Dolgova et al. (2025) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: